RVRC
Revium Rx.
Key Financials
Operating Income
$-1471000
N/A
Net Income
$-13449000
↓ 545.3%
Total Assets
$8.3M
↓ 59.1%
Total Liabilities
$1.4M
↑ 145.7%
EPS (Diluted)
$-0.22
↓ 450.0%
Cash & Equivalents
$1.7M
↓ 48.7%
Shareholders' Equity
$5.5M
N/A
Operating Cash Flow
$-1167000.00
N/A
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 6/22/2026 | View on SEC |
| 8-K | 6/1/2026 | View on SEC |
| 10-Q | 5/14/2026 | View on SEC |
| 8-K | 4/20/2026 | View on SEC |
| 10-K | 3/31/2026 | View on SEC |
| EFFECT | 1/30/2026 | View on SEC |
| S-1/A | 1/28/2026 | View on SEC |
| S-1/A | 1/16/2026 | View on SEC |
| S-1/A | 12/12/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | RVRC |
| Company Name | Revium Rx. |
| CIK | 1839140 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 6467684285 |